|

Diabetes Clinical Trials in Raleigh, NC

53 recruiting studies within 50 miles

Phase
Trial Phase Dist.
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU'sN/A<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Phase 3<1 mi
A Food As Medicine Approach to Address Food Insecurity in Rural North CarolinaN/A<1 mi
Assessment of AI Program 'DRISTi' as a Screening Tool—<1 mi
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot UlcersN/A<1 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot UlcersN/A<1 mi
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or OverweightPhase 3<1 mi
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes MellitusPhase 2<1 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TLPhase 4<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing DialysisPhase 2/3<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 38 mi
Personalized Environment and Genes Study—15 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1DPhase 121 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A21 mi
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US—21 mi
Role of Aging and Individual Variation in Exercise Training ResponsivenessN/A21 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 421 mi
Intraoperative OCT Guidance of Intraocular Surgery II—21 mi
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot UlcersPhase 221 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)N/A21 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)N/A21 mi
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.Phase 121 mi
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 DiabetesN/A21 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 421 mi
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMARTN/A25 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 DiabetesPhase 325 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related ComorbidityPhase 325 mi
Pilot of Continuous Glucose Monitor-Augmented Food Is MedicineN/A25 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesPhase 225 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 225 mi
Transformative Research in Diabetic Nephropathy—25 mi
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and DiabetesN/A25 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)Phase 225 mi
HLA Demographics Study in Adults With Type 1 Diabetes—25 mi
Registry for Stage 2 Type 1 Diabetes—25 mi
Food as Medicine for HIV and DiabetesN/A25 mi
Rare and Atypical Diabetes Network—25 mi
CGM for Management of Type 2 Diabetes in PregnancyN/A25 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersN/A25 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePhase 325 mi
Fenofibrate for Prevention of DR WorseningPhase 325 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 325 mi
REAL-Fam Feasibility Study for Youth Diabetes ManagementN/A25 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 325 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPhase 325 mi
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 DiabetesPhase 325 mi
Preventing Type 2 Diabetes in Black Emergent AdultN/A25 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 225 mi
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)N/A25 mi
Healthy Living Anson StudyN/A25 mi
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment AloneN/A37 mi
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)Phase 449 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.